Avalo Therapeutics, Inc. (AVTX)
14.41
-1.51
(-9.48%)
USD |
NASDAQ |
Apr 08, 16:00
15.48
+1.07
(+7.43%)
After-Hours: 20:00
Avalo Therapeutics Price : 14.41 for April 8, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 211.59 |
| Corcept Therapeutics, Inc. | 41.87 |
| Catalyst Pharmaceuticals, Inc. | 25.31 |
| Relmada Therapeutics, Inc. | 7.01 |
| Theravance Biopharma, Inc. | 16.60 |
Price Related Metrics
| PS Ratio | 2980.75 |
| Price to Book Value | 3.584 |
| Earnings Yield | -46.68% |
| Market Cap | 328.38M |